| NDC Code | 0378-6203-05 |
|---|
| Package Description | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0378-6203-05) |
|---|
| Product NDC | 0378-6203 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Verapamil Hydrochloride |
|---|
| Proprietary Name Suffix | Pm |
|---|
| Non-Proprietary Name | Verapamil Hydrochloride |
|---|
| Dosage Form | CAPSULE, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20070809 |
|---|
| End Marketing Date | 20191130 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA078306 |
|---|
| Manufacturer | Mylan Pharmaceuticals Inc. |
|---|
| Substance Name | VERAPAMIL HYDROCHLORIDE |
|---|
| Strength | 300 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA] |
|---|